ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as ...

The tentative approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate ...

A new study has investigated how different medications and therapies compare with placebos in treating ADHD symptoms. Attention deficit hyperactivity disorder, or ADHD, was long thought to be a ...

Attention disorders such as ADHD arise when the brain struggles to separate important signals from irrelevant noise. At any moment, the brain is flooded with information, and staying focused depends ...

New ADHD pipeline leverages TAAP™ and MPAR® technologies to improve safety for patients ~ SAN DIEGO, CALIFORNIA / ACCESS ...

Stimulant drugs and another medication – atomoxetine – appear to be the best treatment for managing symptoms of ADHD, a study suggests. Monique Wüstenhagen/dpa Talking therapy and brain stimulation ...

"We've had to work on her study skills, but there's no way she'd go back to taking the drugs." While doctors don't endorse patients with /topics/Attention_Deficit_Disorders" ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

Stimulant drugs that are widely used in the treatment of attention-deficit/hyperactivity disorder (ADHD) have a different ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that China's National Medical Products Administration ...